We are live on
!
Find out more
AHC
Adell Harriman & Carpenter Portfolio holdings
AUM
$1.64B
1-Year Est. Return
36.77%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+36.77%
3 Year Est. Return
+127.52%
5 Year Est. Return
+176.12%
10 Year Est. Return
+571.5%
AUM
$1.29B
AUM Growth
+$80.4M
(+6.6%)
Cap. Flow
+$2.82M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
42.84%
Holding
167
New
2
Increased
63
Reduced
76
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Main Street Capital
MAIN
|
+$4.2M |
| 2 |
CrowdStrike
CRWD
|
+$4.09M |
| 3 |
KKR & Co
KKR
|
+$3.47M |
| 4 |
Emerson Electric
EMR
|
+$2.64M |
| 5 |
Marvell Technology
MRVL
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.08M |
| 2 |
NVIDIA
NVDA
|
+$3.58M |
| 3 |
Mondelez International
MDLZ
|
+$3.05M |
| 4 |
Toronto Dominion Bank
TD
|
+$2.66M |
| 5 |
Prologis
PLD
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.33% |
| 2 | Financials | 13.28% |
| 3 | Energy | 8.38% |
| 4 | Healthcare | 6.8% |
| 5 | Industrials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
151
Permian Resources
PR
$17.8B
| $233K | 0.02% |
14,411
| – | – |
|
152
Devon Energy
DVN
$52.1B
| $233K | 0.02% |
4,910
-3,200
| -39% | -$159K |
|
153
ProShares UltraShort S&P500
SDS
$415M
| $230K | 0.02% |
2,000
-500
| -20% | -$62.9K |
|
154
Bristol-Myers Squibb
BMY
$133B
| $225K | 0.02% |
5,410
-458
| -8% | -$20.5K |
|
155
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $223K | 0.02% |
7,075
-1,850
| -21% | -$58.2K |
|
156
Applied Materials
AMAT
$403B
| $212K | 0.02% |
+898
| New | +$193K |
|
157
Agilent Technologies
A
$39.1B
| $207K | 0.02% |
1,594
-750
| -32% | -$105K |
|
158
GE Aerospace
GE
$374B
| $206K | 0.02% |
1,293
-150
| -10% | -$23.9K |
|
159
CVS Health
CVS
$133B
| – | – |
-28,842
| Closed | -$2.3M |
|
160
Deere & Co
DE
$160B
| – | – |
-491
| Closed | -$202K |
|
161
Fidelity International High Dividend ETF
FIDI
$362M
| – | – |
-11,900
| Closed | -$249K |
|
162
Gilead Sciences
GILD
$162B
| – | – |
-4,780
| Closed | -$350K |
|
163
IQVIA
IQV
$38.7B
| – | – |
-858
| Closed | -$217K |
|
164
lululemon athletica
LULU
$13.5B
| – | – |
-525
| Closed | -$205K |
|
165
Nike
NKE
$61.9B
| – | – |
-2,562
| Closed | -$241K |
|
166
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| – | – |
-2,174
| Closed | -$206K |
|
|
EXE
167
Expand Energy Corp
EXE
$21.8B
| – | – |
-2,950
| Closed | -$262K |
|
Similar funds
UMC
LIA
ECM
GA
1SP
MRG
TCA
Adell Harriman & Carpenter's Q2 2024 Portfolio in Review
As of Q2 2024, Adell Harriman & Carpenter held 167 positions worth $1.29B, up 6.6% from $1.21B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Adell Harriman & Carpenter's Q2 2024 filing shows 2 new, 63 increased, 76 reduced and 9 closed positions. Its largest new stake was Accenture: 1,486 shares worth $451K. The largest sale was Johnson & Johnson, an estimated $4.08M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Energy.
- Adell Harriman & Carpenter's largest Q2 2024 buy was Accenture: 1,486 shares worth $451K.
- Adell Harriman & Carpenter added most to Main Street Capital in Q2 2024, an estimated $4.2M increase.
- Adell Harriman & Carpenter's biggest Q2 2024 reduction was Johnson & Johnson, cutting an estimated $4.08M.
- Adell Harriman & Carpenter fully exited CVS Health in Q2 2024, selling an estimated $2.3M.
- Adell Harriman & Carpenter's ten largest holdings make up 43% of its $1.29B portfolio in Q2 2024.
- Adell Harriman & Carpenter opened 2 new positions and closed 9 in Q2 2024.
- Adell Harriman & Carpenter's portfolio value rose 6.6% quarter-over-quarter to $1.29B.
Based on Adell Harriman & Carpenter's 13F filing for Q2 2024, filed 1 Aug 2024.